Zealand Pharma Logo

Zealand Pharma

ISIN: DK0060257814 | Ticker: ZEAL | LEI: 549300ITBB1ULBL4CZ12
Sector: Health CareSub-Industry: Biotechnology
Country: Denmark

About Zealand Pharma

Company Description

Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other rare disease areas with significant unmet medical needs. Zealand employs more than 300 people in Denmark and the US and has a portfolio of medicines and product candidates, including license collaborations with Boehringer Ingelheim.

Our pipeline focusing on gastrointestinal, metabolic and other specialty diseases where we believe that the present standard of care is inadequate and where we have the resources to advance our peptide-based product candidates into the later stages of clinical development, including registration and commercialization, while opportunistically considering partnership relationships that may arise.

Year founded

1998

Headquarters

Sydmarken 11, 2860 Søborg – Denmark

Financial statements

Download as Excel
Line item in (dkk) 01.01.2018 01.01.2019 01.01.2020 01.07.2020 01.10.2020 01.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 01.04.2022 01.07.2022 01.10.2022 01.01.2023 01.04.2023 01.07.2023 01.10.2023
Assets N/A N/A 1,599,514,000.00 N/A N/A 1,761,949,000.00 N/A 1,924,173,000.00 1,660,699,000.00 2,067,629,000.00 1,837,382,000.00 1,256,554,000.00 1,091,608,000.00 1,539,806,000.00 N/A 2,049,678,000.00 2,175,505,000.00
Noncurrent Assets N/A N/A 172,464,000.00 N/A N/A 342,261,000.00 N/A 348,736,000.00 346,818,000.00 346,033,000.00 255,484,000.00 255,826,000.00 257,723,000.00 223,454,000.00 N/A 205,808,000.00 209,571,000.00
Property Plant And Equipment N/A N/A 39,708,000.00 N/A N/A 85,040,000.00 N/A 85,393,000.00 83,308,000.00 86,455,000.00 64,036,000.00 64,868,000.00 62,655,000.00 50,528,000.00 N/A 48,819,000.00 46,843,000.00
Intangible Assets Other Than Goodwill N/A N/A N/A N/A N/A 57,485,000.00 N/A 55,327,000.00 54,710,000.00 53,790,000.00 2,531,000.00 2,531,000.00 2,531,000.00 0.00 N/A N/A 8,840,000.00
Copyrights Patents And Other Industrial Property Rights Service And Operating Rights N/A N/A 2,480,000.00 N/A N/A 57,485,000.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Noncurrent Receivables N/A N/A N/A N/A N/A N/A N/A N/A N/A 29,094,000.00 N/A N/A N/A 18,105,000.00 N/A 20,499,000.00 19,576,000.00
Noncurrent Prepayments N/A N/A 0.00 N/A N/A 13,117,000.00 N/A 11,349,000.00 10,491,000.00 16,457,000.00 16,456,000.00 14,779,000.00 16,456,000.00 N/A N/A N/A N/A
Deferred Tax Assets N/A N/A 0.00 N/A N/A 8,370,000.00 N/A 5,077,000.00 8,344,000.00 13,525,000.00 6,738,000.00 0.00 0.00 2,017,000.00 N/A 1,983,000.00 2,036,000.00
Current Tax Assets Noncurrent N/A N/A 0.00 N/A N/A 1,268,000.00 N/A 1,268,000.00 1,268,000.00 1,268,000.00 1,268,000.00 2,750,000.00 4,125,000.00 0.00 N/A 2,750,000.00 4,125,000.00
Other Noncurrent Financial Assets N/A N/A N/A N/A N/A N/A N/A N/A N/A 0.00 N/A 6,779,000.00 6,921,000.00 6,901,000.00 N/A 7,131,000.00 7,508,000.00
Noncurrent Investments Other Than Investments Accounted For Using Equity Method N/A N/A 35,632,000.00 N/A N/A 32,333,000.00 N/A 33,427,000.00 34,682,000.00 26,907,000.00 29,736,000.00 31,786,000.00 33,857,000.00 30,943,000.00 16,194,000.00 16,194,000.00 13,444,000.00
Longterm Deposits N/A N/A 9,012,000.00 N/A N/A 16,650,000.00 N/A 16,842,000.00 17,051,000.00 12,638,000.00 11,580,000.00 11,420,000.00 11,614,000.00 N/A N/A N/A N/A
Current Assets N/A N/A 1,427,050,000.00 N/A N/A 1,419,688,000.00 N/A 1,575,438,000.00 1,313,881,000.00 1,721,596,000.00 1,581,898,000.00 1,000,728,000.00 833,885,000.00 1,316,352,000.00 N/A 1,843,870,000.00 1,965,934,000.00
Inventories N/A N/A 0.00 N/A N/A 65,040,000.00 N/A 106,216,000.00 116,359,000.00 118,436,000.00 3,760,000.00 818,000.00 0.00 1,286,000.00 N/A 12,823,000.00 10,711,000.00
Trade And Other Current Receivables N/A N/A N/A N/A N/A N/A N/A N/A N/A 153,453,000.00 N/A N/A N/A 115,622,000.00 N/A 117,077,000.00 351,052,000.00
Current Trade Receivables N/A N/A 751,000.00 N/A N/A 46,484,000.00 N/A 99,296,000.00 80,489,000.00 73,025,000.00 71,083,000.00 45,032,000.00 33,560,000.00 N/A N/A N/A N/A
Current Prepaid Expenses N/A N/A 30,755,000.00 N/A N/A 35,156,000.00 N/A 39,731,000.00 30,469,000.00 64,626,000.00 63,817,000.00 52,742,000.00 41,475,000.00 N/A N/A N/A N/A
Other Current Receivables N/A N/A 7,935,000.00 N/A N/A 9,942,000.00 N/A 16,267,000.00 12,144,000.00 15,802,000.00 5,051,000.00 13,365,000.00 4,240,000.00 N/A N/A N/A N/A
Current Tax Assets Current N/A N/A 7,101,000.00 N/A N/A 5,500,000.00 N/A 30,995,000.00 25,442,000.00 21,562,000.00 16,448,000.00 24,327,000.00 24,724,000.00 21,599,000.00 N/A 21,596,000.00 21,982,000.00
Cash and cash equivalents 588,718,000.00 860,635,000.00 1,081,060,000.00 1,350,986,000.00 1,231,685,000.00 960,221,000.00 1,307,554,000.00 987,777,000.00 753,599,000.00 1,129,103,000.00 1,123,235,000.00 553,242,000.00 493,755,000.00 1,069,234,000.00 831,078,000.00 327,686,000.00 384,441,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale N/A N/A N/A N/A N/A N/A N/A N/A N/A 0.00 156,404,000.00 N/A N/A N/A N/A N/A N/A
Current Restricted Cash And Cash Equivalents N/A N/A N/A N/A N/A N/A N/A N/A N/A 0.00 N/A N/A 151,171,000.00 N/A N/A N/A N/A
Current Derivative Financial Assets N/A N/A N/A N/A N/A N/A N/A N/A N/A 0.00 142,100,000.00 N/A N/A N/A N/A N/A N/A
Current Investments N/A N/A 299,448,000.00 N/A N/A 297,345,000.00 N/A 295,155,000.00 295,379,000.00 299,042,000.00 0.00 311,202,000.00 N/A N/A N/A N/A N/A
Equity And Liabilities N/A N/A 1,599,514,000.00 N/A N/A 1,761,949,000.00 N/A 1,924,173,000.00 1,660,699,000.00 2,067,629,000.00 1,837,382,000.00 1,256,554,000.00 1,091,608,000.00 1,539,806,000.00 N/A 2,049,678,000.00 2,175,505,000.00
Equity N/A 1,116,281,000.00 1,242,673,000.00 1,799,922,000.00 1,590,003,000.00 1,229,311,000.00 1,662,746,000.00 1,386,736,000.00 1,185,746,000.00 927,803,000.00 709,697,000.00 504,947,000.00 366,440,000.00 815,911,000.00 N/A 1,727,435,000.00 1,816,796,000.00
Issued Capital N/A N/A 36,055,000.00 N/A N/A 39,800,000.00 N/A 43,542,000.00 43,582,000.00 43,634,000.00 43,634,000.00 46,527,000.00 46,538,000.00 51,702,000.00 N/A 58,642,000.00 58,677,000.00
Retained Earnings N/A N/A -1,443,524,000.00 N/A N/A -2,290,253,000.00 N/A -2,829,253,000.00 -3,028,140,000.00 870,014,000.00 -3,531,247,000.00 439,378,000.00 301,371,000.00 749,592,000.00 N/A 1,650,417,000.00 1,746,826,000.00
Share Premium N/A N/A 2,650,142,000.00 N/A N/A 3,470,787,000.00 N/A 4,161,367,000.00 4,157,533,000.00 4,250,306,000.00 4,253,020,000.00 N/A N/A N/A N/A N/A N/A
Treasury Shares N/A N/A N/A N/A N/A N/A N/A N/A N/A 71,890,000.00 71,890,000.00 N/A N/A N/A N/A N/A N/A
Liabilities N/A N/A 356,841,000.00 N/A N/A 532,638,000.00 N/A 537,437,000.00 474,953,000.00 1,139,826,000.00 1,127,685,000.00 751,607,000.00 725,168,000.00 723,895,000.00 N/A 322,243,000.00 358,709,000.00
Noncurrent Liabilities N/A N/A 161,707,000.00 N/A N/A 177,378,000.00 N/A 161,840,000.00 164,257,000.00 805,509,000.00 797,520,000.00 490,024,000.00 499,241,000.00 528,404,000.00 N/A 121,132,000.00 101,085,000.00
Noncurrent Payables N/A N/A N/A N/A N/A N/A N/A N/A N/A 18,426,000.00 N/A N/A N/A 19,058,000.00 N/A 19,058,000.00 0.00
Noncurrent Deferred Income Including Noncurrent Contract Liabilities N/A N/A N/A N/A N/A N/A N/A N/A N/A 14,551,000.00 2,113,000.00 0.00 0.00 0.00 N/A N/A N/A
Other Noncurrent Liabilities N/A N/A 0.00 N/A N/A 16,744,000.00 N/A 18,227,000.00 18,227,000.00 18,426,000.00 18,427,000.00 18,426,000.00 18,426,000.00 N/A N/A N/A N/A
Longterm Borrowings N/A N/A N/A N/A N/A N/A N/A N/A N/A 647,906,000.00 661,933,000.00 358,035,000.00 368,520,000.00 401,346,000.00 392,668,000.00 0.00 0.00
Current Liabilities N/A N/A 195,134,000.00 N/A N/A 355,260,000.00 N/A 375,597,000.00 310,696,000.00 334,317,000.00 330,165,000.00 261,583,000.00 225,927,000.00 195,491,000.00 N/A 201,111,000.00 257,624,000.00
Trade And Other Current Payables N/A N/A N/A N/A N/A N/A N/A N/A N/A 266,387,000.00 N/A N/A N/A 180,762,000.00 N/A 186,324,000.00 242,652,000.00
Trade And Other Current Payables To Trade Suppliers N/A N/A 57,533,000.00 N/A N/A 70,384,000.00 N/A 76,222,000.00 54,908,000.00 64,558,000.00 42,420,000.00 34,833,000.00 36,158,000.00 N/A N/A N/A N/A
Current Deferred Income Including Current Contract Liabilities N/A N/A N/A N/A N/A N/A N/A N/A N/A 53,033,000.00 54,514,000.00 31,238,000.00 16,100,000.00 0.00 N/A N/A N/A
Current Tax Liabilities Current N/A N/A 614,000.00 N/A N/A 30,394,000.00 N/A 0.00 0.00 N/A N/A N/A N/A N/A N/A N/A N/A
Liabilities Included In Disposal Groups Classified As Held For Sale N/A N/A N/A N/A N/A N/A N/A N/A N/A 0.00 8,932,000.00 N/A N/A N/A N/A N/A N/A
Other Current Liabilities N/A N/A 73,044,000.00 N/A N/A 150,555,000.00 N/A 185,945,000.00 151,550,000.00 173,134,000.00 135,804,000.00 149,717,000.00 151,605,000.00 N/A N/A N/A N/A
Line item in (dkk) 01.01.2018/
01.01.2019
01.01.2019/
01.01.2020
01.01.2020/
01.07.2020
01.01.2020/
01.10.2020
01.01.2020/
01.01.2021
01.04.2020/
01.07.2020
01.07.2020/
01.10.2020
01.01.2021/
01.04.2021
01.01.2021/
01.07.2021
01.01.2021/
01.10.2021
01.01.2021/
01.01.2022
01.04.2021/
01.07.2021
01.06.2021/
01.10.2021
01.07.2021/
01.10.2021
01.01.2022/
01.04.2022
01.01.2022/
01.07.2022
01.01.2022/
01.10.2022
01.01.2022/
01.01.2023
01.04.2022/
01.07.2022
01.06.2022/
01.10.2022
01.07.2022/
01.10.2022
01.01.2023/
01.04.2023
01.01.2023/
01.07.2023
01.01.2023/
01.10.2023
01.04.2023/
01.07.2023
01.07.2023/
01.10.2023
Revenue 37,977,000.00 41,333,000.00 233,432,000.00 289,958,000.00 192,001,000.00 221,016,000.00 56,526,000.00 5,704,000.00 42,251,000.00 95,114,000.00 108,546,000.00 36,547,000.00 54,188,000.00 106,407,000.00 15,077,000.00 43,451,000.00 80,061,000.00 103,986,000.00 28,374,000.00 43,714,000.00 43,714,000.00 N/A 24,036,000.00 319,553,000.00 10,407,000.00 295,517,000.00
Other Income N/A N/A 858,000.00 37,724,000.00 N/A 751,000.00 36,866,000.00 254,000.00 488,000.00 614,000.00 759,000.00 234,000.00 126,000.00 73,000.00 112,000.00 1,849,000.00 1,854,000.00 N/A 1,738,000.00 27,000.00 N/A N/A N/A N/A N/A N/A
Profit Loss From Operating Activities 652,385,000.00 -587,942,000.00 -230,912,000.00 -449,120,000.00 -626,235,000.00 -53,710,000.00 -218,207,000.00 -261,133,000.00 -551,886,000.00 -568,662,000.00 -784,317,000.00 -290,753,000.00 -158,479,000.00 -211,803,000.00 -301,997,000.00 -539,197,000.00 -596,184,000.00 -837,153,000.00 -237,200,000.00 -162,076,000.00 -162,076,000.00 N/A -364,039,000.00 -318,759,000.00 -195,365,000.00 45,279,000.00
Finance Income 9,988,000.00 14,655,000.00 904,000.00 900,000.00 2,022,000.00 2,180,000.00 3,799,000.00 22,589,000.00 11,511,000.00 29,427,000.00 41,211,000.00 0.00 18,548,000.00 18,548,000.00 153,505,000.00 111,891,000.00 130,776,000.00 133,270,000.00 -41,614,000.00 18,885,000.00 18,885,000.00 N/A 19,197,000.00 52,651,000.00 11,760,000.00 33,454,000.00
Finance Costs 37,322,000.00 3,390,000.00 9,907,000.00 19,649,000.00 49,314,000.00 8,026,000.00 13,545,000.00 2,750,000.00 6,061,000.00 7,907,000.00 15,781,000.00 14,389,000.00 2,477,000.00 2,477,000.00 20,472,000.00 173,730,000.00 184,197,000.00 268,158,000.00 153,259,000.00 10,467,000.00 10,467,000.00 N/A 171,531,000.00 177,437,000.00 137,445,000.00 5,905,000.00
Profit Loss Before Tax 625,051,000.00 -576,677,000.00 -239,915,000.00 -467,869,000.00 -673,527,000.00 -59,556,000.00 -227,953,000.00 -241,294,000.00 -546,436,000.00 -547,142,000.00 -758,887,000.00 -305,142,000.00 -142,408,000.00 -195,732,000.00 -168,964,000.00 -601,036,000.00 -649,605,000.00 -972,041,000.00 -432,073,000.00 -153,658,000.00 -153,658,000.00 N/A -516,373,000.00 -443,545,000.00 -321,050,000.00 72,828,000.00
Income Tax Expense Continuing Operations 43,773,000.00 -5,136,000.00 -2,306,000.00 -1,686,000.00 -4,814,000.00 -1,375,000.00 621,000.00 904,000.00 -6,832,000.00 -2,944,000.00 -3,949,000.00 -7,737,000.00 -998,000.00 3,155,000.00 12,076,000.00 12,435,000.00 -5,056,000.00 -6,431,000.00 358,000.00 -1,776,000.00 -1,776,000.00 N/A -3,239,000.00 -4,556,000.00 -1,548,000.00 -1,317,000.00
Profit Loss From Continuing Operations N/A N/A N/A N/A -668,713,000.00 N/A N/A -242,198,000.00 -539,604,000.00 -544,198,000.00 -754,938,000.00 -297,405,000.00 -141,410,000.00 N/A -181,040,000.00 -613,471,000.00 -644,549,000.00 -965,610,000.00 -432,431,000.00 -151,882,000.00 -151,882,000.00 N/A -513,134,000.00 -438,989,000.00 -319,502,000.00 74,145,000.00
Profit Loss From Discontinued Operations N/A N/A N/A N/A -178,016,000.00 N/A N/A 14,000.00 604,000.00 -193,689,000.00 -263,211,000.00 590,000.00 -57,477,000.00 N/A -41,805,000.00 -97,874,000.00 -215,138,000.00 -236,525,000.00 -56,069,000.00 3,540,000.00 3,540,000.00 N/A 0.00 0.00 0.00 0.00
Profit (loss) 581,278,000.00 -571,541,000.00 -237,609,000.00 -466,183,000.00 -846,729,000.00 -58,181,000.00 -228,574,000.00 -242,184,000.00 -539,000,000.00 -737,887,000.00 -1,018,149,000.00 -296,815,000.00 -198,887,000.00 -198,887,000.00 -222,845,000.00 -711,345,000.00 -859,687,000.00 -1,202,135,000.00 -488,500,000.00 -148,342,000.00 -148,342,000.00 -193,632,000.00 -513,134,000.00 -438,989,000.00 -319,502,000.00 74,145,000.00
Profit Loss Attributable To Owners Of Parent 581,278,000.00 -571,541,000.00 N/A N/A -846,729,000.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Line item in (dkk) 01.01.2018 01.01.2019 01.01.2020 01.07.2020 01.10.2020 01.01.2021 01.04.2021 01.07.2021 01.10.2021 01.01.2022 01.04.2022 01.07.2022 01.10.2022 01.01.2023 01.04.2023 01.07.2023 01.10.2023
Profit (loss) N/A 581,278,000.00 -571,541,000.00 -58,181,000.00 -228,574,000.00 -846,729,000.00 -242,184,000.00 -296,815,000.00 -198,887,000.00 -1,018,149,000.00 -222,845,000.00 -488,500,000.00 -148,342,000.00 -1,202,135,000.00 -193,632,000.00 -319,502,000.00 74,145,000.00
Other Adjustments For Noncash Items N/A N/A N/A 39,337,000.00 87,607,000.00 63,862,000.00 -49,586,000.00 -92,581,000.00 33,015,000.00 17,430,000.00 -79,934,000.00 143,029,000.00 192,960,000.00 269,622,000.00 N/A 180,147,000.00 169,600,000.00
Interest Paid Classified As Operating Activities N/A N/A N/A 3,406,000.00 5,862,000.00 4,562,000.00 962,000.00 3,190,000.00 5,347,000.00 3,296,000.00 11,642,000.00 17,713,000.00 20,004,000.00 34,414,000.00 N/A 20,341,000.00 26,872,000.00
Interest Received Classified As Operating Activities N/A N/A N/A 897,000.00 901,000.00 895,000.00 N/A 0.00 0.00 0.00 N/A 1,226,000.00 3,045,000.00 5,178,000.00 N/A 15,665,000.00 22,217,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 39,500,000.00 -93,000.00 0.00 0.00 0.00 0.00 44,740,000.00 46,971,000.00 41,631,000.00 -183,000.00 700,000.00 -1,436,000.00 -9,277,000.00 N/A -236,000.00 -226,000.00
Cash Flows From Used In Operating Activities N/A -461,420,000.00 -409,455,000.00 -313,518,000.00 -411,628,000.00 -688,716,000.00 -368,132,000.00 -695,703,000.00 -904,257,000.00 -1,211,971,000.00 -317,011,000.00 -543,920,000.00 -669,927,000.00 -942,209,000.00 N/A -372,480,000.00 -485,183,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A N/A N/A N/A N/A 0.00 N/A 0.00 0.00 0.00 N/A 104,852,000.00 104,852,000.00 106,386,000.00 N/A 0.00 0.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 0.00 0.00 167,725,000.00 167,725,000.00 167,791,000.00 N/A 0.00 0.00 0.00 N/A N/A N/A 0.00 N/A N/A N/A
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 0.00 25,000.00 N/A N/A 0.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 4,038,000.00 21,036,000.00 14,392,000.00 29,491,000.00 25,044,000.00 4,480,000.00 3,858,000.00 5,854,000.00 22,133,000.00 3,738,000.00 4,759,000.00 5,083,000.00 11,710,000.00 N/A 3,686,000.00 4,522,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 0.00 2,480,000.00 N/A N/A 0.00 N/A N/A N/A N/A N/A N/A 0.00 N/A N/A N/A 8,840,000.00
Dividends Received Classified As Investing Activities N/A 1,020,000.00 878,000.00 N/A N/A 0.00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Cash Flows From Used In Investing Activities N/A 882,925,000.00 -51,666,000.00 -186,428,000.00 -200,799,000.00 -196,807,000.00 -4,828,000.00 -4,050,000.00 -6,255,000.00 -18,121,000.00 294,248,000.00 101,399,000.00 178,566,000.00 281,259,000.00 N/A -1,260,893,000.00 -1,100,731,000.00
Proceeds From Issuing Shares N/A 0.00 645,145,000.00 794,929,000.00 794,929,000.00 791,503,000.00 748,974,000.00 748,975,000.00 748,975,000.00 748,975,000.00 0.00 274,776,000.00 274,775,000.00 1,060,825,000.00 N/A 1,500,000,000.00 1,500,000,000.00
Payments To Acquire Or Redeem Entitys Shares N/A N/A N/A N/A 0.00 0.00 N/A N/A 28,595,000.00 28,590,000.00 N/A 0.00 0.00 0.00 N/A 41,600,000.00 41,600,000.00
Proceeds From Borrowings Classified As Financing Activities N/A N/A N/A N/A N/A 0.00 N/A N/A 0.00 647,906,000.00 N/A N/A 0.00 0.00 N/A N/A N/A
Repayments Of Borrowings Classified As Financing Activities N/A N/A N/A N/A N/A 0.00 N/A 0.00 0.00 0.00 N/A 417,340,000.00 436,088,000.00 436,088,000.00 N/A 525,764,000.00 525,764,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 158,311,000.00 8,689,000.00 15,281,000.00 10,246,000.00 29,219,000.00 2,896,000.00 2,883,000.00 8,195,000.00 14,715,000.00 3,461,000.00 4,225,000.00 10,246,000.00 13,719,000.00 N/A 6,351,000.00 9,035,000.00
Cash Flows From Used In Financing Activities N/A -155,449,000.00 674,480,000.00 770,249,000.00 780,826,000.00 760,941,000.00 703,536,000.00 715,929,000.00 686,440,000.00 1,332,751,000.00 -3,461,000.00 -154,942,000.00 -178,535,000.00 587,398,000.00 N/A 897,384,000.00 901,416,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 266,056,000.00 213,359,000.00 270,303,000.00 168,399,000.00 -124,582,000.00 330,576,000.00 16,176,000.00 -224,072,000.00 102,659,000.00 -26,224,000.00 -597,463,000.00 -669,896,000.00 -73,552,000.00 -231,365,000.00 -735,989,000.00 -684,498,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A 5,861,000.00 7,066,000.00 -376,000.00 -17,775,000.00 3,743,000.00 16,757,000.00 11,380,000.00 17,450,000.00 66,223,000.00 20,356,000.00 21,602,000.00 34,548,000.00 13,683,000.00 N/A -5,559,000.00 -295,000.00
Cash and cash equivalents 588,718,000.00 860,635,000.00 1,081,060,000.00 1,350,986,000.00 1,231,685,000.00 960,221,000.00 1,307,554,000.00 987,777,000.00 753,599,000.00 1,129,103,000.00 1,123,235,000.00 553,242,000.00 493,755,000.00 1,069,234,000.00 831,078,000.00 327,686,000.00 384,441,000.00

Please note that some sums might not add up.

Filings & Publications

2020

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2023

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
/ ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

DK0060257814

LEI

549300ITBB1ULBL4CZ12

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Nasdaq Copenhagen

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.